Re: Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
http://academic.oup.com/jnci/article-pdf/100/21/1557/18074379/djn341.pdf
Reference7 articles.
1. Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
2. Sorafenib in Advanced Hepatocellular Carcinoma
3. Non-Hodgkin's Lymphoma in Patients With Glioma Treated With Temozolomide
4. Pharmacokinetic (PK) and phase I study of sorafenib (S) for solid tumors and hematologic malignancies in patients with hepatic or renal dysfunction (HD or RD): CALGB 60301
5. New designs for the selection of treatments to be tested in randomized clinical trials
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice;Biochemical Pharmacology;2022-06
2. UCK2 regulated by miR-139-3p regulates the progression of hepatocellular carcinoma cells;Future Oncology;2022-03
3. Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE);Cancer Imaging;2021-08-12
4. Bioinformatic gene analysis for potential biomarkers and therapeutic targets of diabetic nephropathy associated renal cell carcinoma;Translational Andrology and Urology;2020-12
5. Enhanced CT Textures Derived From Computer Mathematic Distribution Analysis Enables Arterial Enhancement Fraction Being an Imaging Biomarker Option of Hepatocellular Carcinoma;Frontiers in Oncology;2020-08-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3